HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$3.40
Day range
$3.30 - $3.44
Year range
$0.50 - $3.44
Market cap
515.99M USD
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 34.67M | 17.07% |
Operating expense | 26.42M | -28.58% |
Net income | -3.16M | 90.36% |
Net profit margin | -9.11 | 91.77% |
Earnings per share | -0.02 | 92.59% |
EBITDA | -4.11M | 87.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 71.52M | 19.16% |
Total assets | 217.89M | -1.35% |
Total liabilities | 251.65M | 8.33% |
Total equity | -33.77M | — |
Shares outstanding | 150.65M | — |
Price to book | -15.45 | — |
Return on assets | -5.45% | — |
Return on capital | -8.24% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.16M | 90.36% |
Cash from operations | -9.52M | 61.78% |
Cash from investing | 1.28M | -96.53% |
Cash from financing | 11.00K | 105.29% |
Net change in cash | -8.23M | -170.16% |
Free cash flow | -9.55M | 34.68% |
About
Founded
1983
Headquarters
Website
Employees
126